CADDIE™ Computer-Aided Detection (CADe) Device

by Odin Medical Ltd. (an Olympus Corporation company)  · Based in United States → — Cloud-based AI for endoscopy, supporting doctors to detect and characterize polyps during colonoscopy procedures.
Colorectal Surgery Gastroenterology Radiology

Per procedure cost effectiveness
Regulatory Status Disclosed

Overview

CADDIE™ is a cutting-edge, cloud-based Artificial Intelligence (AI) system developed by Odin Medical Ltd., an Olympus Corporation company. It is designed to assist gastroenterologists in real-time detection and characterization of suspected colorectal polyps during colonoscopy procedures. The system analyzes colonoscopy video in real-time, providing visual markers (a clear green rectangle) and audible alerts to draw the endoscopist’s attention to potential polyps. CADDIE also aids in polyp characterization, helping trained endoscopists differentiate between adenoma and non-adenoma tissue, which can lead to same-day results for patients. Furthermore, CADDIE offers features for assessing bowel cleanliness by displaying the percentage of visible mucosa and identifying the Appendiceal Orifice (AO) to remind users to activate polyp detection during the withdrawal phase. CADDIE operates as standalone software deployed on the cloud, accessed via a web browser, and integrates with existing clinical workflows and endoscopy equipment, including Olympus’ EVIS X1 and EVIS EXERA III systems. It is vendor-neutral and can be used with a single or second monitor.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI Polyp Detection (real-time visual markers and audible alerts)
  • AI Polyp Characterization (differentiates adenoma/non-adenoma)
  • AI Bowel Cleanliness (visible mucosa percentage display)
  • AI Caecum (AO Confirmation and polyp detection reminder)
  • Cloud Technology (real-time analysis, remote updates)
  • Vendor Neutrality (integrates with various endoscopy equipment)
  • Easy to Use (minimal training, hands-free interaction)
  • Seamless integration with existing clinical workflows
  • Supports single or dual monitor configurations
  • Secure data streaming technology

Use Cases

  • Assisting gastroenterologists in real-time detection of suspected colorectal polyps during colonoscopy procedures.
  • Improving adenoma detection rates (ADR) during colonoscopies, particularly for high-risk and hard-to-detect lesions.
  • Aiding in the characterization of colorectal polyps as adenoma or non-adenoma for optical diagnosis.
  • Enhancing colonoscopy quality by monitoring bowel cleanliness and confirming caecal intubation.
  • Supporting earlier detection of colorectal cancer and improving patient outcomes.
  • Providing real-time support to endoscopists, acting as a 'second pair of eyes' to reduce missed lesions.

What Physicians Need to Know

Evidence Base
CADDIEu2122 is trained on a robust dataset enriched with clinically relevant and hard-to-detect lesions, including flat sessile serrated lesions (SSLs) and large polyps (u226510 mm). The system utilizes convolutional neural networks for computer-assisted detection and diagnosis of polyps.
Clinical Validation Studies
The EAGLE Trial, a multicenter randomized controlled study across eight centers in four European countries, evaluated the CADDIEu2122 device. The study, involving 841 patients and 22 endoscopists, showed a 7.3% absolute increase in adenoma detection rate (ADR) with CADDIEu2122 compared to standard colonoscopy. Significant relative increases in detection were observed for large (>10 mm) adenomas (93%), non-polypoid adenomas (57%), and SSLs (230%). Another multi-center randomized controlled trial in the UK with 739 patients showed CADDIEu2122 improved mean ADR to 33.3% with CADDIE vs. 25.2% without.
Alert Fatigue Management
While not specifically detailed for CADDIEu2122, general research on CADe systems suggests that alert fatigue can occur, potentially diminishing effectiveness in later-day procedures. CADDIEu2122 uses visual information and audio alerts to direct attention to regions of interest.
Override Rate Data
The endoscopist is responsible for reviewing CADDIEu2122 suspected polyp areas and confirming the presence or absence of a polyp based on their own medical judgment. The system is intended to assist, not replace, a comprehensive patient evaluation or primary interpretation of endoscopic procedures.
Differential Diagnosis Support
In Europe, CADDIEu2122 covers both computer-aided detection (CADe) and diagnosis (CADx) of suspected colorectal polyps, enabling users to characterize highlighted tissue as adenoma or non-adenoma. However, in the U.S., CADDIEu2122 is available with only polyp detection capabilities and excludes polyp characterization features.
Guideline Update Frequency
As a cloud-based AI solution, CADDIEu2122 receives instant and automatic updates, ensuring clinicians have access to the latest AI without requiring on-site engineers or downtime.
Clinical Workflow Integration
CADDIEu2122 has a simple and user-friendly interface that integrates into the current clinical workflow. It can be configured for single or dual monitor use and integrates with existing clinical workflows and endoscopy equipment, not being tied to a single manufacturer. It can be used as a standalone computer or via the cloud. The system offers hands-free interaction during the procedure, with detection and characterization controlled by a foot pedal. CADDIEu2122 also supports navigation and workflow with features like automatic identification of the ileocecal valve, detection of the appendiceal orifice, and assessment of bowel cleanliness.
Decision Audit Trail
While not explicitly detailed for CADDIEu2122, general FDA guidance for CADe devices applied to radiology images and data recommends developing an audit trail to minimize the risk of tuning to test data and maintain data integrity.
Physician Tip

CADDIEu2122 is an AI-powered tool designed to assist in real-time colorectal polyp detection during colonoscopies, particularly for high-risk and hard-to-detect lesions. Remember that CADDIEu2122 is a supplementary aid; your independent clinical judgment remains paramount for confirming polyp presence, classification, and determining treatment plans. In regions where CADx is available, leverage its characterization function to aid in optical diagnosis. Utilize the cloud-based updates to ensure you are always working with the latest AI advancements. Be mindful of potential alert fatigue during longer procedures and maintain vigilance. The system's integration features, such as automatic identification of anatomical landmarks, can further streamline your workflow.

CADDIEu2122 is a cloud-based software solution that integrates with the Olympus EVIS X1u2122 and EVIS EXERAu2122 III endoscopy systems. It can be deployed as a standalone computer or accessed via the cloud, connecting to the endoscopy processor and monitor through a secure web browser and hospital internet network. This cloud-based architecture allows for instant and automatic software updates. CADDIEu2122 is part of the OLYSENSEu2122 Intelligent Endoscopy Ecosystem, which aims to integrate clinical and operational solutions, providing data connectivity across the GI unit and integration with hospital systems.

Details

Category Clinical Decision Support & Reference, Gastroenterology AI, Radiology & Imaging AI
Pricing Per procedure cost effectiveness
DeploymentCloud-based (standalone software accessed via web browser)
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Colorectal Surgery, Gastroenterology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CADDIE™ Computer-Aided Detection (CADe) Device

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for CADDIE™ Computer-Aided Detection (CADe) Device.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Like all CADe systems, CADDIEu2122 can generate false positives, leading to additional work-up or patient anxiety. It's crucial for physicians to understand that CADDIEu2122 is a decision support tool, not a diagnostic one, and clinical judgment remains paramount in interpreting its findings and avoiding unnecessary interventions.
While CADDIEu2122 is designed for intuitive use, proper training on its features, interpretation of its markers, and understanding its limitations is essential for optimal performance and to ensure compliance with best practices in radiology. Manufacturers typically provide training programs and resources.
CADDIEu2122 differentiates itself through its proprietary algorithms and potentially superior performance metrics in specific scenarios. While other CADe and AI solutions exist, CADDIEu2122 aims to offer a balance of high sensitivity and specificity, with ongoing updates to its AI models to improve accuracy and reduce false positives.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

More from Odin Medical Ltd. (an Olympus Corporation company)

Odin CADDIE™
Olympus America
Gastroenterology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-07 | First Added: 2026-07-07
AI Tool Finder
AI-powered search. Results may not be comprehensive.